Literature DB >> 23611784

Fibroblast growth factor-2 up-regulates the expression of nestin through the Ras-Raf-ERK-Sp1 signaling axis in C6 glioma cells.

Kai-Wei Chang1, Yuan-Li Huang, Zong-Ruei Wong, Peng-Han Su, Bu-Miin Huang, Tsai-Kai Ju, Hsi-Yuan Yang.   

Abstract

Nestin is a 240-kDa intermediate filament protein expressed mainly in neural and myogenic stem cells. Although a substantial number of studies have focused on the expression of nestin during development of the central nervous system, little is known about the factors that induce and regulate its expression. Fibroblast growth factor-2 (FGF-2) is an effective mitogen and stimulates the proliferation and differentiation of a subset of nestin-expressing cells, including neural progenitor cells, glial precursor cells, and smooth muscle cells. To assess whether FGF-2 is a potent factor that induces the expression of nestin, C6 glioma cells were used. The results showed that nestin expression was up-regulated by FGF-2 via de novo RNA and protein synthesis. Our RT-PCR results showed that C6 glioma cells express FGFR1/3, and FGFRs is required for FGF-2-induced nestin expression. Further signaling analysis also revealed that FGF-2-induced nestin expression is mediated through FGFR-MAPK-ERK signaling axis and the transcriptional factor Sp1. These findings provide new insight into the regulation of nestin in glial system and enable the further studies on the function of nestin in glial cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611784     DOI: 10.1016/j.bbrc.2013.04.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Uptake and Toxicity of Copper Oxide Nanoparticles in C6 Glioma Cells.

Authors:  Arundhati Joshi; Wiebke Rastedt; Kathrin Faber; Aaron G Schultz; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2016-08-03       Impact factor: 3.996

2.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

Review 3.  Metabolic regulation of glioma stem-like cells in the tumor micro-environment.

Authors:  Tom M Thomas; John S Yu
Journal:  Cancer Lett       Date:  2017-07-22       Impact factor: 8.679

4.  Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery.

Authors:  Thomas Gaj; Brett T Staahl; Gonçalo M C Rodrigues; Prajit Limsirichai; Freja K Ekman; Jennifer A Doudna; David V Schaffer
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

5.  GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17.

Authors:  Subbroto Kumar Saha; Hye Yeon Choi; Gwang-Mo Yang; Polash Kumar Biswas; Kyeongseok Kim; Geun-Ho Kang; Minchan Gil; Ssang-Goo Cho
Journal:  Mol Ther Oncolytics       Date:  2020-04-14       Impact factor: 7.200

6.  Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension.

Authors:  Aneel R Bhagwani; Schuyler Hultman; Daniela Farkas; Rebecca Moncayo; Kaivalya Dandamudi; Arsema K Zadu; Carlyne D Cool; Laszlo Farkas
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

Review 7.  Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.

Authors:  Elena Codrici; Ana-Maria Enciu; Ionela-Daniela Popescu; Simona Mihai; Cristiana Tanase
Journal:  Stem Cells Int       Date:  2016-02-10       Impact factor: 5.443

8.  The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis.

Authors:  Quan Zhou; Xiongyan Wu; Xiaofeng Wang; Zhenjia Yu; Tao Pan; Zhen Li; Xinyu Chang; Zhijian Jin; Jianfang Li; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  Oncogene       Date:  2019-10-28       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.